On June 25, the Listing Committee of the Shanghai Stock Exchange made a public announcement stating that the initial public offering (IPO) application of Shenzhen CoreCardio Technology Co., Ltd. (hereinafter referred to as CoreCardio) has been slated for a review session on July 2. This move aligns with the standard procedures of the stock exchange, where companies seeking to go public undergo a rigorous evaluation process to ensure compliance with regulatory standards and market readiness.